471 filings
Page 5 of 24
4
xqv5ard4
10 Jan 23
ANAPTYSBIO / DENNIS M FENTON ownership change
7:06pm
4
g97umo
10 Jan 23
ANAPTYSBIO / Daniel Faga ownership change
7:04pm
8-K
u7ung4b hp5x5d
5 Jan 23
AnaptysBio Announces Portfolio Update Across Best-in-Class Immune Cell Modulating Antibodies
4:12pm
424B5
pbgo3f tz
8 Nov 22
Prospectus supplement for primary offering
4:34pm
8-K
r6lo ssmr3aqbp0
8 Nov 22
AnaptysBio Announces Third Quarter 2022 Financial Results and Provides Pipeline Update
4:08pm
4
bcy m504zeb6pluy
16 Sep 22
ANAPTYSBIO / Paul F. Lizzul ownership change
5:08pm
4
xdgo8yny
16 Sep 22
ANAPTYSBIO / ERIC J LOUMEAU ownership change
5:07pm
4
ch4a5kry
16 Sep 22
ANAPTYSBIO / DENNIS MULROY ownership change
5:06pm
8-K
f5e9 s4c9mm
12 Sep 22
Entry into a Material Definitive Agreement
7:32am
SC 13G
kurnvgz8zue68to36olz
9 Sep 22
ANAPTYSBIO / Point72 Asset Management ownership change
4:54pm
8-K
o21zs763tf
31 Aug 22
AnaptysBio Reports HARP Phase 2 Top-Line Data of Imsidolimab in Moderate-to-Severe Hidradenitis Suppurativa
4:19pm
SC 13G
dduzpzuwu3z
15 Aug 22
ANAPTYSBIO / Flynn James E ownership change
5:47pm
4
zzl6r483o c5hhaot
9 Aug 22
ANAPTYSBIO / ERIC J LOUMEAU ownership change
12:00am
8-K
3ttqpx305fu2h29m
8 Aug 22
AnaptysBio Announces Second Quarter 2022 Financial Results and Provides Pipeline Update
4:21pm
4
zokdj fxw
27 Jun 22
ANAPTYSBIO / DENNIS MULROY ownership change
7:06pm
4
uxjjrzjang lj0
27 Jun 22
ANAPTYSBIO / ERIC J LOUMEAU ownership change
7:04pm
4
lw7nod5ba0a
27 Jun 22
ANAPTYSBIO / Paul F. Lizzul ownership change
7:03pm
8-K
h5r6b1m4 10pve42o
24 Jun 22
Submission of Matters to a Vote of Security Holders
4:05pm